Askin tumor

Summary

Askin tumor (MONDO:0006094) is a cancer and 2 clinical trials. A subtype of thoracic cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	Askin tumor
Mondo ID	MONDO:0006094
EFO	EFO:1000095
MeSH	C563168
DOID	DOID:0050608
NCIT	C7542
UMLS	C0877849
MedGen	209112
GARD	0024291
Anatomy (UBERON)	UBERON:0002224
Is cancer (heuristic)	yes

Also known as: Askin tumor · Askin’s tumor · peripheral neuroectodermal tumor of thoracopulmonary region · peripheral neuroectodermal tumour of thoracopulmonary region · PNET of thoracopulmonary region · small cell tumor of thoracopulmonary region · small cell tumour of thoracopulmonary region

Data availability: 16 cell lines.

Disease family

This is a subtype of thoracic cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › thoracic cancer › Askin tumor

Related subtypes (7): heart cancer, sternum cancer, mediastinal cancer, pleural cancer, breast cancer, lung cancer, malignant neoplasm of chest wall

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE2	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00563680	PHASE2	COMPLETED	QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing’s Family Tumor and Desmoplastic Small Round Cell Tumors
NCT00899990	Not specified	COMPLETED	Collecting and Storing Biological Samples From Patients With Ewing Sarcoma